Bharat Immunologicals Profit Margin

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Profit Margin Analysis

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Bharat Immunologicals 
Profit Margin 
 = 
Net Income 
Revenue 
X
100 
 = 
0.38 %

About Profit Margin

In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has Profit Margin of 0.38%. This is much higher than that of the Healthcare sector, and significantly higher than that of Profit Margin industry, The Profit Margin for all stocks is over 1000% lower than the firm.

Peer Comparison

Bharat Immunologicals Profit Margin Comparison
Bharat Immunologicals is currently under evaluation in profit margin category among related companies.

Did you try this?

Run Portfolio Reporting Now
   

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
All  Next Launch Portfolio Reporting

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Fundamental Indicators

Current Bharat Immunologicals financial ratios